Resham Ramkissoon, MD

Excited to announce the 60th citywide Tavill Rounds! @CWRU_GI @UHhospitals @ClevelandClinic @metrohealthCLE @cwruim #livertwitter

Congratulations to Dr. Damjanovska on this amazing milestone! Make us proud! @CWRU_GI @MDAndersonNews @UHhospitals

July 1st is a special day at teaching hospitals. New opportunities to inspire and nurture new residents and fellows. A new challenge to be a better educator. Welcome @TurkYahia, @elise_leonard, Akash Chavan to @cwrugi & @UHhospitals! #GITwitter @cwruim

Phenomenal narrative review of SBP prophylaxis by @vinayjaha in @LiverFellow. Discusses the literature, new and old, and the emerging antibiotic resistance. Certainly something to share with my trainees! @CWRU_GI @cwruim aasld.org/liver-fellow-n…

The June issue of the #RedJournal is here!   Explore this month's articles, including TWO new ACG Clinical Guidelines: Ulcerative Colitis & Crohn's Disease!   📕 amjgastro.com @MLongMD @JasmohanBajaj @AndrewMMoon @TrieuMD

This paper studies how parental alcohol use disorder and #liverdisease related mortality influence the risk and the outcomes of alcohol-associated #hepatitis in offspring. #LiverTransplant @Dr_Vijay_Shah @DougSimonetto @HepCommJournal bit.ly/3SX9jS7

📑 Comparative effectiveness of different #corticosteroid regimens in severe #alcohol-associated hepatitis‼️ ❌ difference in 30-day ☠️ between prednisolone, prednisone, or methylprednisolone journals.lww.com/hepcomm/fullte…

💊 DOACs in cirrhosis 🗣️ Cindy Pereira Portela (Lausanne) – #EASL2025 ✅ Child A/B: ok (⚠️ no rivaroxaban in B) 🚫 Child C: not recommended ⭐ Apixaban might be the winner — but more data needed 🧩 Case-by-case decision 🤝 Multidisciplinary approach is essential

SYMMETRY #efruxifermin study in compensated cirrhosis @EASLedu #EASLCongress by @NoureddinMD The upshot is shown below at wk 96 ITT 🔼 fibrosis 18% “Completer” 🔼 fibrosis 24% Improved NITs Reduced placebo adjusted BMD by 5%. No imbalance in fracture rate. #livertwitter

Important study in @NEJM ❤️ seeing @NoureddinMD front page! 😁for treatments to reverse #cirrhosis ⚠️careful not to over interpret negative phase 2b with *signals* 🧐everyone should learn about FGF21, a fascinating hormone at the intersection of liver metabolism and fibrogenesis

May is Hepatitis Awareness Month, raising awareness of the importance of vaccination for hep A & hep B, testing for hep B & hep C, the availability of effective care & curative treatment, and the serious health consequences resulting from undiagnosed & untreated viral hepatitis.

Outstanding review of AAT deficiency in @HEP_Journal. Bookmarked this one as a reminder of: ✅️Genetics & Pathophysiology ✅️AAT phenotypes ✅️SZ phenotype and ⬆️ cancer risk ✅️Controversies with plasma-purified AAT @cwruim @CWRU_GI #livertwitter journals.lww.com/hepcomm/fullte…

Your liver is the foundation of your health. This #WorldLiverDay, let's care for it together one healthy choice at a time. #MASLD #FoodIsMedicine @WorldLiverDay youtube.com/watch?v=e3YV5N…

Quite a shocking read about the state of organ allocation in the US. Thank you, @nytimes, for highting the issue. I hope that we can find a way to rebalance the system I was trained in. @UHhospitals #Livertwitter nytimes.com/interactive/20…

Save the date for the 11th annual MetroGI symposium in August! Great talks and fantastic speakers! our featured lineup for our non GI friends: will be updates on GERD management/evaluation, HCV treatment and noninvasive testing in liver disease. Please come, enjoy, and network!

Immune checkpoint inhibitor (ICI) before liver transplant ⬆️ rejection. 💡New study in @HEP_Journal reveals a 50-days washout period is optimal for safety, cutting rejection significantly. #livertwitter #HCC #immunotherapy #transplant